Building on the success of Rosa Khutor resort, the $1 bln project will bring quality hotels and rehabilitation facilities, new skiing tracks for over a million of visitors per year while creating thousands of new jobs MoreTopicsInterros / VEB.RF / Vasta Discovery / Sochi
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax- was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
The first place in the nomination «Medicine of choice for the treatment and prevention of SARS and influenza among children» was granted to «Polyoxidonium», produced by NGO Petrovax Pharm.